AwardTape · Defense awards · Medical · Health care services · HT001525D9032
HT001525D9032: $0 IDIQ contract to Servefed GMS JV, LLC
Servefed GMS JV, LLC holds an IDIQ contract from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $43.0B. Latest action May 7, 2026.
Medical q-coded services and support next generation contract staff
| PIID | HT001525D9032 |
|---|---|
| Type | IDIQ contract |
| Company | Servefed GMS JV, LLC |
| Agency | Defense Health Agency |
| Contracting office | DHA ENTERPRISE MED SUPPORT EMS-CD |
| Category | Medical · Health care services |
| PSC | Q201 MEDICAL- MANAGED HEALTHCARE |
| NAICS | 621111 OFFICES OF PHYSICIANS (EXCEPT MENTAL HEALTH SPECIALISTS) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $43.0B |
| Base date | Jun 9, 2025 |
| Latest action | May 7, 2026 |
| End date | n/a |
| Actions since Oct 2023 | 3 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| HT001525F0061 delivery order | Servefed GMS JV, LLC | $2.5K | Medical q-coded support and services next generation post award conference | Defense Health Agency | Health care services | Jun 9, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial